Efficacy and Safety of Adjunctive Recombinant Human Interleukin-2 for Patients with Pulmonary Tuberculosis: A Meta-Analysis

Figure 5

Forest plots for the meta-analysis of the effect of rhuIL-2 on the proportion of patients with radiographic cavity closure; (a), forest plots for the overall meta-analysis; (b), forest plots for the subgroup analysis according to the drug sensitivity of TB; and (c), forest plots for the subgroup analysis in newly diagnosed and recurrent TB.

(a)

(b)

(c)